A detailed history of Dld Asset Management, LP transactions in Allakos Inc. stock. As of the latest transaction made, Dld Asset Management, LP holds 435,668 shares of ALLK stock, worth $143,770. This represents 0.02% of its overall portfolio holdings.

Number of Shares
435,668
Previous 435,668 -0.0%
Holding current value
$143,770
Previous $100,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$0.23 - $1.24 $100,203 - $540,228
435,668 New
435,668 $100,000

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $28M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Dld Asset Management, LP Portfolio

Follow Dld Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dld Asset Management, LP with notifications on news.